This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
The Role of the Family Physician in Achieving Optimal Outcomes in Moderate to Severe Atopic Dermatitis

The Role of the Family Physician in Achieving Optimal Outcomes in Moderate to Severe Atopic Dermatitis

Format

Patient Case Study

Time to Complete

1 hour

Released

September 27, 2019

Expires

September 27, 2020
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM

Accredited Provider



Provided by Integrity Continuing Education.

Commercial Supporter

Supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

Program Description

Atopic dermatitis (AD) is frequently misdiagnosed in clinical practice due to a lack of standardized terminology and tests, causing inappropriate treatment of AD to also be widely prevalent in current clinical practice. In addition to gaps in patient care, financial burden and limitations to access may reduce the effectiveness of treatment in patients with AD. Several lines of evidence have confirmed that patients with moderate to severe AD report poor quality of life due to inadequately controlled disease. Primary care clinicians play a pivotal role in the management of patients with AD by referring patients with moderate to severe AD to a specialist, providing ongoing maintenance care after specialist evaluation, and managing patients with mild or more episodic AD themselves.

Intended Audience

This educational initiative has been designed for family physicians, family nurse practitioners, and physician assistants involved in the management of patients with AD.

Educational Objectives

Upon completion of this educational activity, participants should be able to:

  • Utilize updated criteria and guidelines to accurately diagnose AD
  • Assess and document disease severity in individual patients
  • Review updated guidelines and evaluate available clinical data for therapies utilized in the treatment of AD
  • Describe indications for specialist referral of patients with AD and review best practices for co-management of moderate to severe disease with specialist physicians

Conflict Of Interest Disclosure Policy

Integrity Continuing Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Integrity Continuing Education is committed to providing learners with high-quality CME/CE activities and related materials that promote improvement or quality in healthcare and not a specific proprietary business interest or a commercial interest.

The faculty/planners reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity.

Faculty

Eric L. Simpson, MD, MCR
Professor of Dermatology
Department of Dermatology
Oregon Health & Science University
Portland, Oregon

Dr. Simpson discloses the following:
Consulting Fees: AbbVie; Eli Lilly; Forte Bio Rx; Orhto Dermatologics; Pfizer; Pierre Fabre Dermo Cosmetiue; Sanofi Genzyme and Regeneron Pharmaceuticals
Contracted Research: AbbVie; Eli Lilly; Kyowa Hakko Kirin; Leo Pharma; Pfizer; Sanofi Genzyme and Regeneron Pharmaceuticals

Accredited Provider Disclosure

Michelle R. Rizzo, ELS, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians.

Designation Statement

Integrity Continuing Education, Inc. designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Integrity Continuing Education and Sanofi Genzyme and Regeneron Pharmaceuticals do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education and Sanofi Genzyme and Regeneron Pharmaceuticals. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

The information provided in this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Instructions

There are no fees for participating and receiving CME credit for this activity. During the period of September 27, 2019 through September 27, 2020, participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pre-test
  • Study the educational activity
  • Complete the post-test and the evaluation form
A certificate will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or higher. Please proceed with the activity until you have successfully passed the post-test, completed the evaluation and received a digital copy of your credit certificate. Pharmacists much check the CPE monitor for credits within 60 days of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education, Inc., at (855) 835-4004 or information@integrityce.com.

If you have any questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue